Exosomes in tumor microenvironment influence cancer progression and metastasis

C Kahlert, R Kalluri - Journal of molecular medicine, 2013 - Springer
Exosomes are small membrane vesicles of endocytic origin with a size of 50–100 nm. They
can contain microRNAs, mRNAs, DNA fragments, and proteins, which are shuttled from a …

The epidermal growth factor receptor variant III (EGFR v III): where wild things are altered

HK Gan, AN Cvrljevic, TG Johns - The FEBS journal, 2013 - Wiley Online Library
The epidermal growth factor receptor (EGFR) is overexpressed in a variety of human
epithelial tumors, often as a consequence of gene amplification. Tumors with EGFR gene …

Glioblastoma, a brief review of history, molecular genetics, animal models and novel therapeutic strategies

S Agnihotri, KE Burrell, A Wolf, S Jalali… - Archivum immunologiae …, 2013 - Springer
Glioblastoma (GBM) is the most common and lethal primary brain tumor. Over the past few
years tremendous genomic and proteomic characterization along with robust animal models …

Diagnostic and therapeutic avenues for glioblastoma: no longer a dead end?

S Tanaka, DN Louis, WT Curry, TT Batchelor… - Nature reviews Clinical …, 2013 - nature.com
Glioblastomas are heterogeneous neoplasms that are driven by complex signalling
pathways, and are among the most aggressive and challenging cancers to treat. Despite …

EGFR phosphorylates tumor-derived EGFRvIII driving STAT3/5 and progression in glioblastoma

QW Fan, CK Cheng, WC Gustafson, E Charron… - Cancer cell, 2013 - cell.com
EGFRvIII, a frequently occurring mutation in primary glioblastoma, results in a protein
product that cannot bind ligand, but signals constitutively. Deducing how EGFRvIII causes …

KRAS mutations in lung cancer

N Karachaliou, C Mayo, C Costa, I Magrí… - Clinical lung cancer, 2013 - Elsevier
Epidermal growth factor receptor (EGFR) gene mutations and increased EGFR copy
numbers have been associated with a favorable response to EGFR tyrosine kinase …

Extracellular vesicles–biomarkers and effectors of the cellular interactome in cancer

J Rak - Frontiers in pharmacology, 2013 - frontiersin.org
In multicellular organisms both health and disease are defined by patterns of communication
between the constituent cells. In addition to networks of soluble mediators, cells are also …

Probabilistic radiographic atlas of glioblastoma phenotypes

BM Ellingson, A Lai, RJ Harris… - American Journal …, 2013 - Am Soc Neuroradiology
BACKGROUND AND PURPOSE: Tumor location is a significant prognostic factor in
glioblastoma, which may reflect the genetic profile of tumor precursor cells. The purpose of …

Lipid metabolism emerges as a promising target for malignant glioma therapy

D Guo, EH Bell, A Chakravarti - CNS oncology, 2013 - Taylor & Francis
Malignant gliomas are one of the most treatment-refractory cancers. Development of
resistance to chemo-and radio-therapies contributes to these tumors 'aggressive …

miR-143 regulates hexokinase 2 expression in cancer cells

A Peschiaroli, A Giacobbe, A Formosa, EK Markert… - Oncogene, 2013 - nature.com
Tumor cells activate pathways that facilitate and stimulate glycolysis even in the presence of
adequate levels of oxygen in order to satisfy their continuous need of molecules, such as …